Topofen: Phase Ib/IIa data

A double-blind, crossover, U.S. Phase Ib/IIa trial in 48 patients ages 18-65 that suffer recurring moderate to severe migraines, defined as

Read the full 211 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE